



Forest therapy can prevent and treat depression: evidence from meta-analyses 1 
 2 
Forest therapy involves engaging in a combination of forest-based activities to improve 3 
one’s health or wellbeing. We conducted an overview of systematic reviews (SRs) and 4 
meta-analyses of primary studies to provide the most comprehensive summary of the 5 
effect of forest therapy on depression. We included 13 primary studies that matched our 6 
eligibility criteria - all were included in four recent SRs and were conducted in the 7 
Republic of Korea. We carried out meta-analyses with data extracted directly from these 8 
13 studies and assessed their risk of bias. Outcomes of interest were depressive 9 
symptoms, temporary recovery from depression (i.e. remission), response to treatment 10 
(i.e. ≥ 50% reduction on depressive symptoms from baseline), adherence to treatment, 11 
and adverse effects. Considering pooled estimates from randomized controlled trials 12 
with adults, we found that compared to no intervention/usual care, forest therapy 13 
produced a greater reduction of depressive symptoms (Hedges’g = 1.18, 95% CI [0.86, 14 
1.50], p < .00001). Also compared to no intervention/usual care, participants in the 15 
forest therapy group were 17 times as likely to achieve remission (Risk Ratio = 17.02, 16 
95% CI [3.40, 85.21], p = .0006) and three times as likely to have a ≥ 50% reduction on 17 
depressive symptoms (Risk Ratio = 3.18, 95% CI [1.94, 5.21], p < .00001). Forest 18 
therapy, on average, reduced depressive symptoms more than engaging in similar 19 
activities in a hospital or non-forested urban area, or participating in an intervention 20 
focused on diet plus forest-based exercise. We did not find evidence that adherence to 21 
forest therapy is different from the adherence to alternative interventions and the 22 
adverse effects of forest therapy appear to be rare. These results indicate that, relative to 23 
many more conventional alternatives, forest therapy is a more effective short-term 24 
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 3 
1. Introduction 4 
Depression is considered one of the most important global health challenges (Cipriani et 5 
al., 2018). More than 300 million people worldwide suffer from this disorder, which can 6 
harm many aspects of life (e.g. affective relationships and work) and, in the worst-case 7 
scenario, lead to suicide (World Health Organization, 2017). Common symptoms of 8 
depression are sad mood, anxiety, insomnia, loss of vitality, and lack of interest in life 9 
(Fried, 2017). Depression is best conceptualized in a continuum ranging from the 10 
presence of a few/mild/rare symptoms to the presence of several/severe/frequent 11 
symptoms that lead to a debilitating life condition (Fried, 2017; van de Leemput et al., 12 
2014). The diagnosis of a person as depressed is based on specific criteria and should 13 
ideally be done through a structured or semi-structured interview (Nordgaard et al., 14 
2013). Considering that depression is understood as a combination of symptoms (Fried, 15 
2017; van de Leemput et al., 2014), interventions designed to prevent or treat 16 
depression should not focus solely on one symptom. By preventing depression, we refer 17 
to a process in which a non-depressed person achieves a reduction in depressive 18 
symptoms. Such a reduction helps this person to remain non-depressed. By treating 19 
depression, we refer to a process in which a depressed person achieves a reduction in 20 
depressive symptoms. 21 
Common treatments for depression are psychotherapy and antidepressants 22 
(Cuijpers, 2018). These have advantages, such as accessibility to treatment, and have 23 
been proven to be efficient in ameliorating depressive symptoms (Cuijpers et al., 2020), 24 




have secondary effects like gastrointestinal symptoms (e.g. nausea and diarrhea), weight 1 
gain, and metabolic abnormalities (Carvalho et al., 2016), and both antidepressants and 2 
psychotherapy lack effectiveness in the short-term (Cuijpers, 2018). Considering these 3 
disadvantages of psychotherapy and antidepressants, researchers have called for 4 
complementary or even alternative treatments for depression (Lopresti, 2019; 5 
Munkholm et al., 2019). One of these alternatives may be direct contact with nature 6 
(Lee et al., 2017; Rajoo et al., 2020; van Tulleken et al., 2018). Specifically, previous 7 
studies have found encouraging results regarding the potential of forest therapy to 8 
prevent and treat depression (e.g. Chun et al., 2017; Kim et al., 2009).  9 
The human health benefits of exposure to trees and forests abound and include 10 
restorative capacities such as stress reduction as well as improvement in clinical mental 11 
health outcomes (Wolf et al., 2020). To maximize these capacities, forest therapy is 12 
often recommended as a form of preventive medicine (Park et al., 2010). Forest therapy, 13 
also known as “shinrin-yoku”(Oh et al., 2017; Park et al., 2010; Rajoo et al., 2020), 14 
involves engaging in a combination of activities in a forest environment to improve 15 
one’s health or wellbeing (Han et al., 2016; Lee et al., 2017; Yu and Hsieh, 2020). 16 
Forest therapy may include forms of forest-based exercise but should involve more than 17 
just physical activity - typically incorporating other activities that foster positive mental 18 
health such as meditation, games using forest elements, and/or group activities (Bang et 19 
al., 2018; Chun et al., 2017; Djernis et al., 2019; Han et al., 2016; Lee et al., 2017; 20 
Rajoo et al., 2019). In urban environments that increase stress and hinder psychological 21 
restoration, direct immersion in forests can help people to calm down and reflect 22 
(Collado et al., 2017; Kaplan, 1995; Kim et al., 2009; Kotera et al., 2020; Mayer et al., 23 
2009; Rajoo et al., 2019). There is evidence that even a short period spent in a forest can 24 




positive emotions (Djernis et al., 2019; Kaplan, 1995; Kotera et al., 2020; Lee et al., 1 
2017; Rajoo et al., 2020; Wen et al., 2019; Yu and Hsieh, 2020). These benefits of 2 
exposure to forests provide insights regarding the value of forest environments and the 3 
relevance of conserving and utilizing these settings to improve human health (Bratman 4 
et al., 2019). 5 
Yet, while an abundance of research suggests forest-based activities produce 6 
positive health outcomes (Hansen et al., 2017; Park et al., 2010), less research has 7 
explored direct links between forest therapy and depression (Wen et al., 2019). For 8 
example, in Wen et al.’s (2019) study of the effects of forest activities on health, only 9 
three out of the 28 studies included in their analyses reported the effect of forest therapy 10 
on depression. Furthermore, because previous evidence synthesis combined results from 11 
depression measures with other constructs, it is difficult to discern if forest therapy is an 12 
effective way of preventing and treating depression, specifically (Djernis et al., 2019; 13 
Kotera et al., 2020). It is also unknown if forest therapy is safe (i.e. are adverse effects 14 
rare?) and acceptable (i.e. do people adhere well to forest therapy?). Such knowledge 15 
gaps limit the development of guidelines for practitioners who might be willing to 16 
employ forest therapy to prevent and treat depression.  17 
We therefore conducted an overview of systematic reviews (SRs) and meta-18 
analyses to answer the following research question: Is there sufficient evidence 19 
supporting forest therapy as an effective intervention to prevent and treat depression? 20 
Our literature review offers four novel contributions. First, to our knowledge, this is the 21 
first review to focus exclusively on the effects of forest therapy on depression. Second, 22 
we included more primary studies that reported depression outcomes than previous SRs, 23 
and used these studies to provide estimates of the effect of forest therapy on depression. 24 




depressive symptoms based on statistical significance or standardized effect estimates, 1 
we considered more interpretable outcomes (Riedel et al., 2010) such as temporary 2 
recovery from depression (i.e. remission), response to treatment (≥ 50% reduction in 3 
depressive symptoms from baseline), and treatment acceptability or adherence (i.e. 4 
drop-outs for any reason). Fourth, different from previous SRs, we assessed the risk of 5 
bias of primary studies using tools that favor the identification of all potential sources of 6 
bias (Sterne et al., 2019, 2016). 7 
 8 
2. Methods 9 
Our overview of SRs and meta-analyses of the effects of forest therapy on depression 10 
was based on guidance from the latest edition of the Cochrane Handbook for Systematic 11 
Reviews of Interventions (Higgins et al., 2019). We began the study by selecting SRs 12 
most relevant to our research question centered on forest therapy and depression. We 13 
located SRs by testing the utility of several databases (e.g., MEDLINE and PsycINFO) 14 
and search terms such as forest therapy, forest bathing, and shinrin-yoku (see 15 
Supplementary File p.1). Through this process, we found three SRs that met our criteria, 16 
and a fourth was later identified via social media for researchers. However, if we were 17 
to interpret only the results of these four SRs (rather than of the primary studies), we 18 
would emerge with a limited answer to our research question. Thus, we decided to 19 
analyze all eligible primary studies included by these four SRs. We did this by 20 
developing our eligibility criteria (Table 1) and synthesis plan (see Supplementary File 21 
p. 1 to 4) based on recent guidance from meta-analysis experts (e.g. Bender et al., 2018; 22 
Higgins et al., 2019).  23 
Regarding the eligibility criteria, we made important distinctions between forest 24 




be in a forest. Forest exercise involves doing physical exercise in a forest, which can 1 
include walking. We operationalized forest therapy to include engagement in a 2 
combination of forest-based activities to improve one’s health or wellbeing. Thus, 3 
forest-based exercise combined with other forest-based activities (e.g. meditation, 4 
psychotherapy, group activities) met our definition of forest therapy. Nonetheless, just 5 
being in a forest or exercising in a forest was not enough to satisfy this definition and 6 
qualify as a forest therapy intervention for this study.  7 
< Table 1 about here > 8 
The first author of the present study collected relevant data from the four SRs, 9 
assessed the eligibility of primary studies (Table 1), gathered relevant data on eligible 10 
primary studies, and assessed the risk of bias of SRs and primary studies. All primary 11 
studies included in our meta-analyses were identified on the four SRs, so the first author 12 
screened primary studies for eligibility based on the information provided by the four 13 
SRs. Decisions regarding the eligibility of primary studies at full-text and their risk of 14 
bias assessment were checked by at least one co-author. Most information describing 15 
primary studies (e.g. sample size) was collected from the four SRs and then checked 16 
within the primary studies (Saldanha et al., 2019). The information used in our meta-17 
analyses was extracted directly from primary studies. The first author checked the 18 
information from primary studies at least once after finishing the data extraction phase. 19 
The risk of bias of the four SRs was assessed using the ROBIS tool (Whiting et 20 
al., 2016). The risk of bias of the primary studies was assessed using the RoB 2 for 21 
randomized controlled trials (RCTs) and cross-over trials (Sterne et al., 2019), and 22 
ROBINS-I for non-randomized controlled trials (NRCT) (Sterne et al., 2016). These are 23 
the most comprehensive tools available to assess potential bias in SRs, RCTs, cross-24 




quasi-random process were classified as RCTs (Sterne et al., 2019). Studies that did not 1 
describe the randomization process or assigned participants to interventions based on a 2 
non-random criterion (e.g. participants’ preference) were classified as NRCTs (Sterne et 3 
al., 2016). 4 
 5 
2.1. Synthesizing Data from Primary Studies 6 
Following recommendations from the Cochrane Handbook, we focused on 7 
results from RCTs and analyzed them separately from cross-overs trials, and NRCTs 8 
(Higgins et al., 2019). Our main outcome was the standardized mean difference (SMD) 9 
between the post-intervention depressive symptoms of two intervention groups. 10 
Depressive symptoms scores are usually calculated by summing the score of items on a 11 
depression rating scale for an individual. These items often cover a specific symptom 12 
frequency and, sometimes, symptom intensity. The mean we used in our analysis was 13 
the average score for the sample group in an intervention (e.g. the post-intervention 14 
average score of the forest therapy group). When primary studies met all criteria needed 15 
to be included in a meta-analysis (see Supplementary File p.1 to 2), we pooled their 16 
SMDs because pooled SMDs are more precise than estimates of effect from single 17 
studies (Higgins et al., 2019). Following Sawilowky (2009), we interpreted SMDs as: 18 
very small = 0.01, small = 0.2, medium = 0.5, large = 0.8, very large = 1.2, and huge = 19 
2.0.  20 
To improve the interpretability of the effect of forest therapy on depression 21 
compared to other interventions, we also considered reductions in depressive symptoms 22 
based on dichotomous outcomes such as remission from depression and response to 23 
treatment (Riedel et al., 2010). Remission refers to a temporary recovery from 24 




symptoms below a specific cut-off  on a validated rating scale” (Cuijpers et al., 2020, p. 1 
93). Response to treatment is usually registered as the number of people who exhibit ≥ 2 
50% reduction of depressive symptoms from baseline following treatment. This 3 
threshold is appropriate for the most commonly used scales to register depression: the 4 
Hamilton Depression Rating Scale (HDRS or HAMD), Montgomery-Asberg 5 
Depression Rating Scale (MADRS), and the Beck Depression Inventory (BDI), but 6 
might not be appropriate for other scales (Riedel et al., 2010). None of the primary 7 
studies we analyzed reported the number of people who responded to treatment (i.e. 8 
responders). Thus, the number of responders in studies using one of these three scales 9 
was estimated using the formula described by Furukawa et al. (2005). We do not report 10 
the number of responders for primary studies that did not use one of these three scales. 11 
We used drop-out for any reason as a proxy for treatment acceptability or adherence 12 
(Cipriani et al., 2018; Cuijpers et al., 2020). For dichotomous outcomes, we calculated 13 
risk ratios as they are easier to interpret than odds ratios (Higgins et al., 2019). We 14 
reported the percentage of reduction in depressive symptoms from baseline in forest 15 
therapy and comparison groups as a descriptive statistic (Vickers, 2001). We describe in 16 
Equation 1 how this percentage was calculated. We also collected and reported 17 
information about any adverse effects of forest therapy treatment described by primary 18 
studies’ authors. 19 
 20 
((Post-intervention mean score - Baseline mean score)/Baseline mean score)*100 21 
 22 
Equation 1 23 
 24 
Statistical analyses were performed using RevMan 5.3 (“Review Manager 25 




primary studies were created using robvis (McGuinness, 2019). Data are publicly 1 
available at: (inserting link when published). 2 
 3 
3. Results 4 
3.1 Results of systematic reviews 5 
Selected characteristics (e.g. research question, eligibility criteria, search strategy, risk 6 
of bias assessment, and main results) of the four SRs that we reviewed are described in 7 
Supplementary File p. 6. By analyzing the eligibility criteria of these SRs, we noted that 8 
they were not able to include: (1) unpublished studies; (2) studies in languages other 9 
than English and Korean; (3) studies published after October 2019; and, (4) within 10 
Korean studies: studies with children or adolescents (< 18 years old), without a 11 
comparison group, or published after 2016.  12 
The four SRs were deemed as at high risk of bias because of limitations that 13 
could hinder the adequate identification, selection, data extraction, appraisal, or 14 
synthesis of relevant primary studies (Table 2). For example, the synthesis methods 15 
used in the four SRs conducted before our review were limited. Moreover, no SR 16 
focused exclusively on the effect of forest therapy on depression. It is possible, 17 
however, to extract some information about the effect of forest therapy on depression 18 
because three of the four SRs reported results for each primary study. Djernis et al.’s 19 
(2019) SR was the only one that did not report results for each primary study. Instead, 20 
the authors provided, for example, a pooled estimate of the effect of forest activities on 21 
a combination of psychological constructs. Kotera et al.’s (2020) SR provided estimates 22 
of the effect of forest therapy on depression, but only for three of the 13 studies 23 
analyzed in our study. The meta-analysis performed by Kotera et al. (2020) combined 24 




state (the Profile of Mood States). More limiting, both Lee et al. (2017) and Wen et al. 1 
(2019) used a vote-counting approach seemingly based on the statistical significance of 2 
findings. While it is good to know if forest therapy is likely to have a positive effect on 3 
depression, patients and practitioners also need to be aware of the magnitude of this 4 
effect to make more informed decisions about the use/promotion of forest therapy. 5 
< Table 2 about here > 6 
Using primary studies, we built upon these SRs to provide more precise 7 
estimates of forest therapy’s impact on depression relative to other alternatives such as 8 
no intervention/usual care or walking in a forest. The analyses presented in the next 9 
section are based on data extracted directly from primary studies that were part of the 10 
four SRs described above. 11 
 12 
3.2 Results of primary studies  13 
The four SRs included a total of 101 primary studies. We eliminated 82 primary 14 
studies because they were duplicates or did not measure depression as defined in our 15 
eligibility criteria (Table 1). Nineteen studies were analyzed at full-text, of which six 16 
were eliminated (reasons for exclusion are provided in Fig. 1 and Supplementary Table 17 
1 in the Supplementary File p. 4). Thus, 13 primary studies were included in our 18 
analyses (see Fig. 1 for a flow diagram and the Supplementary File p. 5 for the 19 
references of all included studies). Primary studies' characteristics are summarized in 20 
Table 3. All studies were conducted in the Republic of Korea (total number of 21 
participants N = 649), and one of them included children. Most participants were older 22 
than 39 years old and the percentage of women across studies varied widely. Two 23 
studies were conducted with people suffering from major depression (Kim et al., 2009; 24 




according to BDI and HDRS (Chun et al., 2017). The other 10 studies did not classify 1 
their participants as depressed or non-depressed. However, considering established cut-2 
off points for diagnosing depression on the scales they used, the baseline mean scores of 3 
these studies indicate that in eight of these 10 studies the average participant was 4 
depressed. The two exceptions were Bang et al. (2018) and Hong (2012). Four studies 5 
were RCTs, two were cross-overs, and seven were NRCTs. Most forest therapy 6 
interventions involved meditation, physical activities, games, or group activities. Most 7 
interventions took a few days or a few weeks, and no intervention was longer than 11 8 
weeks. Across all studies, seven different measures of depression were used. 9 
<Fig. 1 about here> 10 
<Table 3 about here> 11 
Overall, we found support for the effectiveness of forest therapy in reducing 12 
depressive symptoms within RCTs, cross-over trials, and NRCTs with adults. For 13 
example, RCTs found on average a 60% reduction of depressive symptoms from 14 
baseline; the average on cross-over trials was 51% and 22% in NRCT (Table 4). Some 15 
studies provided more than one relevant comparison group, generating a total of five 16 
comparison groups (Table 5). These comparisons were: (1) forest therapy versus no 17 
intervention/usual care (including taking antidepressants as usual); (2) forest therapy 18 
versus similar activities in a hospital; (3) forest therapy versus similar activities in an 19 
urban area; (4) forest therapy versus diet plus exercise in a forest; and, (5) forest therapy 20 
versus walking in a forest. Below, we present results for each comparison. 21 
<Table 4 and 5 about here> 22 
(1) Forest therapy versus no intervention/usual care: Three RCTs assessed this 23 
comparison. The SMD of post-intervention scores was similar in these studies and the 24 




p < .00001, Fig. 2a). Two of these three studies (Kim et al., 2009; Woo et al., 2012) 1 
provided data for remission (operationalized as HRSD score ≤ 7). In these two studies, 2 
participants were taking antidepressants following their usual treatment; we refer to the 3 
group that took only antidepressants as the usual care for depression group. Participants 4 
in the forest groups were 17 times as likely to achieve remission compared to 5 
participants in the usual care for depression group (Risk Ratio = 17.02, 95% CI [3.40, 6 
85.21], p = .0006, Fig. 2b). Also, participants in the forest groups were three times as 7 
likely to respond to treatment (Risk Ratio = 3.18, 95% CI [1.94, 5.21], p < .00001, Fig. 8 
2c). The pooled SMD of NRCTs was similar to that of RCTs (Supplementary Fig. 1 in 9 
the Supplementary File p. 7). The pooled results of two NRCTs that used the BDI scale 10 
indicated that response to treatment was more likely to occur in the forest group, but 11 
these results are inconclusive (Risk Ratio = 1.43, 95% CI [0.78, 2.62], p = .26, see 12 
Supplementary Fig. 2 in the Supplementary File p. 7). 13 
< Fig. 2 about here > 14 
Only one study focused on depression in children. This study assessed the 15 
comparison between forest therapy and no intervention/usual care. In Bang et al. (2018), 16 
there is a considerable imbalance in the baseline depressive symptoms between the 17 
forest group (mean = 12.26) and the no intervention group (mean = 9.39), and an 18 
appropriate method to account for this imbalance was not used. For example, by using 19 
ANCOVA the researchers could have compared the post-test scores while keeping the 20 
baseline score statistically constant (Higgins et al., 2019). Thus, we calculated the mean 21 
change from baseline for each group and its standard deviation based on the available 22 
results. The mean reduction in depressive symptoms from baseline was greater in the 23 
forest therapy group than in the no intervention group, but results are inconclusive 24 




 (2) Forest therapy versus similar activities in a hospital: Two RCTs assessed 1 
this comparison (Kim et al., 2009; Woo et al., 2012). In these RCTs, one group engaged 2 
in forest therapy and the other group performed similar activities to the forest therapy 3 
group but in a hospital. The pooled SMD of the post-intervention scores of the forest 4 
therapy group and the hospital group was medium, favoring forest therapy (Hedges’g = 5 
0.63, 95% CI [0.20, 1.06,], p = .004, Fig. 3a). These studies also reported results for 6 
remission (operationalized as HDRS score ≤ 7). Participants in the forest group were 7 
two times as likely to achieve remission as participants in the hospital group (Risk Ratio 8 
= 1.97, 95% CI [1.22, 3.21], p = .006, Fig. 3b). Participants in the forest group were also 9 
more likely to respond to treatment (Risk Ratio = 1.69, 95% CI [0.98, 2.91], p = .06, 10 
Fig. 3c). One NRCT assessed this comparison (Lim et al., 2014) and found results 11 
similar to the ones of RCTs (Hedges’g = 0.76, 95% CI [0.14, 1.38,], p = .02).  12 
< Fig. 3 about here > 13 
(3) Forest therapy versus similar activities in an urban area: A RCT conducted 14 
with chronic stroke patients compared forest therapy with similar activities done in an 15 
urban environment (Chun et al., 2017). This study found a huge difference between 16 
groups’ post-intervention scores, favoring forest therapy (Hedges’g = 2.60, 95% CI 17 
[1.89, 3.30,], p < .00001). Participants in the forest group were 13 times as likely to 18 
respond to treatment compared to participants in the urban group (Risk Ratio = 13.05, 19 
95% CI [3.41, 49.97], p = .0002). 20 
(4) Forest therapy versus diet plus forest-based exercise: Two cross-over trials 21 
assessed this comparison and measured depression using the BDI. The diet plus exercise 22 
phase of the trial occurred first. After 28 days (the washout period) the forest therapy 23 
phase took place. Hong et al. (2012) found that the forest therapy phase reduced 24 




(reduction on BDI score = -12.76, 95% CI [-18.82, -6.70], p = .0001, Cohen’s d = 1.03). 1 
Hong et al. (2013) found similar results (reduction on BDI score = -4.48, 95% CI [-8.09, 2 
-0.87], p = .01, Cohen’s d = 0.61). We were unable to calculate a Hedges’ g and the 3 
dispersion of the SMDs because these studies did not report the correlation between 4 
individuals’ outcome data between the two phases of the trial. A pooled risk ratio 5 
indicated that, during the forest therapy phase, participants were more likely to respond 6 
to treatment than during the diet plus forest-based exercise phase (Risk Ratio = 3.20, 7 
95% CI [1.33, 7.68], p = .009, see Supplementary Fig. 3 in the Supplementary file p. 7). 8 
(5) Forest therapy versus walking in a forest: One RCT assessed this 9 
comparison (Woo et al., 2012). There was a substantial imbalance in the baseline values 10 
of the forest therapy group (mean = 24.21) and the walking in forest group (mean = 11 
18.47), and an appropriate method to account for this imbalance was not used for this 12 
comparison (e.g. ANCOVA). We were unable to calculate a standard deviation for the 13 
mean change from baseline, so we only report descriptive statistics and differences in 14 
the likelihood of response to treatment. The forest therapy group had a reduction of 50% 15 
in the baseline symptoms and the walking in a forest group a reduction of 32%. 16 
Participants in the forest therapy group were more likely to respond to treatment, but 17 
results are inconclusive (Risk Ratio = 1.25, 95% CI [0.61, 2.57], p = .54). 18 
Finally, we conducted sensitivity analyses to test the robustness of some 19 
decisions taken during the synthesis process (Supplementary File p. 8 to 9). These 20 
analyses suggest that our findings are robust to these decisions. 21 
 22 
3.2.1 Treatment acceptability and adverse effects  23 
Most studies did not provide a flow diagram showing how many participants 24 




use of participant drop-outs as a proxy for treatment acceptability was not optimal. 1 
Nevertheless, drop-outs were documented in six studies. In these studies, the number of 2 
drop-outs for any reason was scarce, and there was no evidence of differences between 3 
intervention groups (Supplementary Fig. 4 in Supplementary File p. 8). Eleven of 13 4 
studies did not present any information about adverse effects (i.e. if they occurred or if 5 
they did not occur). Only two studies reported information about the (no) occurrence of 6 
adverse effects. In one study, a participant developed a rash caused by an insect bite in 7 
the forest (Kim et al., 2009); in the other study, the authors noted that participants 8 
reported no health problems during the forest therapy intervention (Choi and Ha, 2014). 9 
Thus, from a total of 311 people involved in forest therapy, in the 13 primary studies 10 
that we analyzed, only one (0.3%) had an adverse effect reported. 11 
 12 
3.2.2 Risk of bias of primary studies, publication bias, and statistical heterogeneity 13 
We deemed all RCTs and cross-over trials as at high risk of bias (Supplementary 14 
File p. 10) and the NRCTs as at serious risk of bias (Supplementary File p. 12). When 15 
assessing RCTs, cross-overs, and NRCTs, we followed the recommendations of the 16 
tools’ developers to determine the risk of bias for each domain and overall for a specific 17 
result of each study (Sterne et al., 2019, 2016). Additional information about the risk of 18 
bias assessment is provided in the Supplementary File p. 9 to 12.  19 
Due to the small number of studies included in our meta-analyses, it was not 20 
appropriate to test for publication bias (i.e. if results from unpublished studies are 21 
different from the results of published studies; Higgins et al., 2019). For instance, one of 22 
the statistical requirements for using funnel plots to assess publication bias is to include 23 




Only one of the meta-analyses we conducted (Supplementary Fig. 1 in 1 
Supplementary File p. 7) produced substantial statistical heterogeneity, but we did not 2 
try to explain this heterogeneity (e.g. using meta-regression) due to the small number of 3 
studies included in this meta-analysis (Higgins et al., 2019). 4 
 5 
4. Discussion 6 
. In the present study, we analyzed four recent SRs that explored connections 7 
between forest therapy and depression, focusing on forest therapy’s capacity to reduce 8 
depressive symptoms in comparison to no intervention/usual care and four alternative 9 
interventions. Our findings show the effect of forest therapy on depression is greater 10 
than the effect of any alternative intervention. People in forest therapy groups had a 11 
higher reduction in depressive symptoms than people in the other groups.  12 
 13 
When compared to similar interventions in non-forest settings, the benefits of 14 
forest therapy were clear. Being involved in therapeutic activities in a forest appears to 15 
be more effective than participating in such activities in a hospital or in an urban (non-16 
forested) area. Assuming the only difference between the forest therapy group and the 17 
other groups was the intervention setting, these findings suggest that exposure to a 18 
forest environment may provide additional benefits beyond the therapeutic activities 19 
themselves. This is in line with research showing the benefits of exposure to nature, and 20 
forests specifically (Wen et al., 2019; Wolf et al., 2020). For example, Bowler et al. 21 
(2010) conducted meta-analyses of studies comparing the effect of the same activity 22 
conducted in a natural versus a synthetic environment. They found that individuals who 23 
conducted the activities in natural environments expressed less anger, fatigue, and 24 




research conducted under stress reduction theory (Ulrich et al., 1991) and attention 1 
restoration theory (Kaplan, 1995), which have consistently shown that exposure to 2 
natural environments favors stress reduction, mood improvement, and the recovery of 3 
attentional capabilities more than non-natural environments.  4 
Our findings also revealed that forest therapy was more effective than depression 5 
treatment regimens focused on diet plus forest-based exercise. Whereas diet, exercise, 6 
and forest exposure may reduce depressive symptoms, the greater effect of forest 7 
therapy on depression may be explained by the activities in which the forest therapy 8 
groups participated (Djernis et al., 2019; Kim et al., 2009). The distinction between 9 
forest therapy (a combination of activities positive for mental health) and forest exercise 10 
is important. Whereas green exercise can yield a variety of positive health outcomes 11 
(Bowler et al., 2010; Gladwell et al., 2013), forest therapy, which includes other 12 
activities positive for mental health, may be more effective to prevent and treat 13 
depression. Similar conclusions can be drawn for the comparison between forest 14 
therapy and walking in a forest, as the forest therapy group generally had a higher 15 
reduction in depressive symptoms and greater response to treatment than the forest 16 
walking group (although the confidence interval for the estimate of the difference 17 
between these interventions overlaps zero).  18 
Analyzing the number of drop-outs in the intervention groups across the studies 19 
synthesized, we found no evidence that forest therapy was a less acceptable treatment 20 
than other alternatives (Supplementary Fig. 4 in the Supplementary File p. 8). We also 21 
found that the adverse effects of forest therapy may be rare. 22 
  23 




Several limitations should be considered when interpreting the results of our 1 
study. First, we selected only four relevant SRs. Nonetheless, as the last SR we included 2 
(Kotera et al., 2020) did not provide any new primary study, it seems that our approach 3 
was sufficiently comprehensive. Also supporting this view, no new eligible primary 4 
study was found in a recently published SR about the effect of forest activities on 5 
physiological and psychological outcomes (Rajoo et al., 2020).  6 
Second, the screening process of primary studies and subsequent data extraction 7 
was not checked by another reviewer. We judged that it was not necessary to have 8 
another reviewer involved in the screening because this process was relatively simple. 9 
Regarding data extraction, the first author checked the information describing primary 10 
studies and information used in meta-analyses at least once after finishing the data 11 
extraction phase.  12 
Third, although the findings from our meta-analyses are encouraging and 13 
underscore the potential of forest therapy to prevent and treat depression, we should 14 
interpret these findings with some caution due to the limitations of existing primary 15 
studies. Overall, the primary studies included a considerable diversity of participants 16 
(e.g. health and unhealthy people), interventions, comparison groups, outcome 17 
measures, and settings. Nonetheless, young adults were underrepresented, as the mean 18 
age/age range of adults was above 39 years and only one study included children (and it 19 
yielded inconclusive results). Thus, it remains unclear if the effect of forest therapy on 20 
depression is higher or lower on children, adolescents, and young adults.  21 
Fourth, caution should also be executed when interpreting our results because all 22 
the studies included in our review were conducted in the Republic of Korea, as these 23 
were the only studies we located from anywhere in the world that evaluated forest 24 




Considering that forest activities are popular elsewhere in Asia (Yu and Hsieh, 2020), 1 
future research could systematically search for primary studies conducted in countries 2 
such as Japan and Taiwan. This also highlights the need for wider geographic coverage 3 
in research about the forest therapy effect on depression.  4 
Fifth, our inability to incorporate unpublished research also casts some doubt 5 
about the true effectiveness of forest therapy, as there is evidence that studies are more 6 
likely to be published if they reveal statistically significant treatment effects (Higgins et 7 
al., 2019). Although the effect of forest therapy might have been overestimated (or 8 
underestimated), the publication of forest therapy findings is unlikely to be heavily 9 
influenced by financial interests, which favor the publication of positive results, as is the 10 
case for antidepressant studies (Munkholm et al., 2019). We examined the reported 11 
funding and conflict of interest of primary studies and found no evidence of any conflict 12 
of interest. 13 
Finally, methodological limitations of the primary studies in our analyses 14 
increase uncertainty about the true effect of forest therapy on depression. Only four 15 
RCTs and two cross-over trials were included in our meta-analyses, and all had a high 16 
risk of bias. The main limitations of these studies were the lack of blinding, which is 17 
infeasible in forest therapy interventions because people experience the treatment 18 
environment, and the lack of a protocol describing the analysis plan. The former 19 
increases the risk of deviations from the intended intervention and can introduce bias in 20 
the assessment of treatment-related outcomes. The latter hinders the possibility of 21 
assessing selective reporting. Limitations were also identified in the randomization 22 
process and in the way some studies dealt with missing outcome data. Whereas most of 23 
these limitations are typically associated with an exaggeration of experimental 24 




underestimated (Sterne et al., 2019, 2016). Moreover, a NRCT was the only source of 1 
evidence for the impact of forest therapy on children’s depressive symptoms, and other 2 
NRCTs provided additional information for two comparisons (i.e. forest therapy versus 3 
no intervention/usual care, and forest therapy versus similar activities in a hospital). 4 
Similar to RCTs and crossover trials, the NRCTs were not blinded and did not publish 5 
an analysis plan. Besides these limitations, NRCTs tend to have a higher risk of bias 6 
than RCTs due to confounding, as the assignment of participants to the intervention can 7 
be related to baseline variables that influence the outcome (i.e. prognostic factors).  8 
 9 
5. Future research opportunities and conclusions 10 
In summary, future literature reviews may extend the evidence we have 11 
synthesized by systematically searching for unpublished studies, studies in other 12 
languages than English and Korean, and studies with children and adolescents. Future 13 
primary studies should document if (and what) adverse effects occurred in the forest 14 
therapy and comparison group(s) and report remission from depression and response to 15 
treatment. Future research could also examine whether certain aspects of forest therapy 16 
(e.g., meditation vs. green exercise) are more beneficial than others when it comes to 17 
treating depression. It includes assessing if or how different frequency and duration of 18 
forest therapy interventions may influence the reduction in depressive symptoms. The 19 
adoption of relevant Consolidated Standards of Reporting Trials (CONSORT) should 20 
facilitate the assessment of primary studies' risk of bias and the interpretation of their 21 
results (Moher et al., 2010). Our findings also highlight the need for more 22 
methodologically rigorous RCTs examining the effects of forest therapy on depression. 23 
Despite some limitations, our review of SRs and primary studies examining the 24 




yielded the most conclusive evidence to date. Compared to antidepressants, similar 1 
activities in a hospital or non-forested urban settings, or even diet and forest-based 2 
exercise, forest therapy appears to be more likely to produce outcomes like remission 3 
and response to treatment, with adequate acceptability or adherence. Thus, while more 4 
studies are needed, we believe practitioners should consider the use of forest therapy as 5 
both a preventive measure and a treatment for depression in adults. This is in line with 6 
the growing support for the incorporation of therapeutical activities in contact with 7 
nature as a mainstream intervention for the prevention and treatment of mental health 8 
problems (Buckley et al., 2018).    9 
 10 
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Table 1. Eligibility criteria for our overview of systematic reviews examining links 1 
between forest therapy and depression based on participants (P), intervention (I), 2 
comparator (C), outcome (O), and setting (S) (i.e. PICOS) 3 
PICOS 
element 
Inclusion criteria Exclusion criteria 
Participants Studies with humans, healthy or not. Studies not including 
humans. 
Intervention Studies reporting any intervention that 
matched our definition of forest therapy, which 
we defined as engaging in a combination of 
activities in a forest to improve one’s health or 
wellbeing. Moreover, in our definition, a forest 
therapy intervention should include more than 
just exposure to nature or exercising in a 
forest, incorporating other activities positive 
for mental health (e.g. meditation and group 
activities). 
Studies that only involved 
exposure to nature or 
exercising in a forest. 
Comparator Studies with any comparison group and studies 
without a comparison group. 
NA 
Outcome Studies where depression was estimated by 
clinical examination (e.g. by a physician) or by 
a previously developed (not ad hoc) 
instrument (e.g. questionnaire or standardized 
interview such as the DSM-IV) designed to 
diagnose or estimate the intensity of this 
disorder. 
Studies that assessed specific 
depressive symptoms in 
isolation (e.g. mood or 
anxiety). 
Setting Studies of environments that primary study 
authors described as a forest (e.g. urban-forest, 
campus forest, recreational forest). 
Studies not describing a 
forest. 




Table 2. Risk of bias assessment of the systematic reviews included in our overview  1 
Systematic 
Review 




2.  Identification and 
Selection of Studies 





Risk of Bias in 
the Review 
(Lee et al., 
2017) 
     
(Wen et al., 
2019) 
     
(Djernis et 
al., 2019) 
     
(Kotera et 
al., 2020) 
     
 = low risk;  = high risk 2 
Note. Systematic reviews’ risk of bias was assessed using ROBIS (Whiting et al., 2016), 3 
a tool specially designed for this function. As recommended by ROBIS’s developers, 4 
we classified the risk of bias for each systematic review domain (eligibility criteria, 5 
search strategy and selection, data collection and primary studies appraisal, and 6 

























Study design  Setting Data collection 
framework 




39.75 57.4 The intervention included walking 












T1: Just before 
treatment; T2: just 
after  treatment 
Lim 2014 Elderly people 
from a nursing 
facility 
≥ 50 29.7 Activities included strolling in the 
forest, experiencing five senses, 
games, and meditation. 
Eleven weeks Once a week 
for 90 min. 
22 1: (N = 21) Similar 
activities in a hospital;  









Forest T1: Just before 
treatment; T2: just 
after  treatment 
You 2014 Middle-aged 
women 
~ 50 100 Sallimyok (Forest Therapy); 
meditation; walking; Qi-Qong. 







Forest T1: Just before 
treatment; T2: just 
after  treatment 
Choi 2014 Cancer patients ≥ 50 75.47 Activities included meditation, 
touching and lying on the wood, 
and treasure hunt.  
Eight weeks Once a week 
for 120 min. 







Urban forest T1: Just before 
treatment; T2: just 
after  treatment 
Shin 2012 Detoxified 
chronic 
alcoholics 
45.26 8.7 Three days actively interacting 
with nature, three days challenging 
activities in nature, three days 
activities for introspection (e.g. 
nature meditation, counseling in 
nature). 







T1: Just before 
treatment; T2: just 
after treatment 
Chun 2017 Chronic stroke 
patients 
60.8 32.2 Activities included meditation, 
experiencing the forest through all 
five senses, and walking. 
Four days All days 30 (N = 29) Similar 
activities in an urban 
area 




T1: Just before 
treatment; T2: just 





46.91 50 Forest activities included 
handkerchief dyeing, decorating a 
frame using natural items, and 
group work. 
Two weeks Five times (60 
min each time) 









T1: 5 to 10 minutes 
before treatment; 
T2: 5 to 10 minutes 
after treatment; 
Y. G. Kim 
2015 
Cancer patients ---- 84.90 Experiencing feeling (1st day), 
meditation (2nd day), mindfulness 
(3rd day), and feedback.  
Three days All days for 
four hours a day 
27 (N = 26) Normal daily 
routines 





Forest T1: Just before 
treatment; T2: just 
after  treatment 




57.46 83.33 Activities in forests included taking 
herbal medicine, music therapy, 
and Qigong.  
Three days All days, 
several hours 
per day 
15 (N = 15) Conducted 
regular diet and 
exercise program (3 
times a day) in the 
forest 
BDI Crossover trial Saneum Natural 
Recreation 
Forest 
T1: Just before 
treatment; T2: just 
after  treatment 
Hong 2012 Hwa-Byung 
patients 
51.6 90 Activities in forests included taking 
herbal medicine, music therapy, 
and Qigong.  
Three days All days, 
several hours 
per day 
16 (N = 16) Conducted 
regular diet and 
exercise program (3 
times a day) in the 
forest 
BDI Crossover trial Saneum Natural 
Recreation 
Forest 
T1: Just before 
treatment; T2: just 
after  treatment 
 
  





45.68 ---- Forest activities included 
cognitive-behavioral therapy, 
meditation, and relaxation training.  
Four weeks Once a week 
(for 3 hours) 
28 1: (N = 21) Similar 
activities in a hospital; 
2: (N = 15) Treatment 
as usual; 








T1: Just before 
treatment; T2: just 
after  treatment 
Bang 2018 Elementary-
school students 




11.79 55.56 Forest activities included five 
senses experience, walking, and 
games. 
Ten weeks Once a week 
(for 60 min) 








Urban forest T1: Just before 
treatment; T2: just 
after  treatment 





46.2 85.7 Forest activities included 
cognitive-behavioral therapy, 
positive psychology tools, and 
mindfulness meditation on breath, 
wind, forest, and sounds. 
Four weeks Once a week 
(three 
hours/session) 
23 1: (N = 19) Similar 
activities in a hospital; 









T1: Just before 
treatment; T2: T1 + 
1 week;  
T3: T1 + 2 weeks;  
T4: T1 + 3 weeks 
Note: *When results for more than one outcome measure were available, we gave preference to results from one outcome measure based on 
specific criteria (see Supplementary File p. 2 for more information). The chosen measures are in bold. Underlined studies were written in Korean. 




Table 4. Percentage of reduction in depressive symptoms from baseline for forest therapy and other interventions, listed by primary study 
First author and 
year 
Groups 
 Forest therapy Similar activities in a 
hospital 




Diet plus exercise in the 
forest 
Walking in a 
forest 
Randomized controlled trials 
Chun 2017 -77.46 NA -1.39 NA NA NA 
Kim 2009 -50.08 -19.91 NA -7.57 NA NA 
Shin 2012 -64.04 NA NA 0.20 NA NA 
Woo 2012 -50.27 -34.81 NA -10.10 NA -32.49 
Mean (SD) -60.46 (13.08) -27.36 (10.54) -1.39 -5.82 (5.37) NA -32.49 
Median -57.16 -27.36 -1.39 -7.57 NA -32.49 
Cross-over trials 
Hong 2013 -46.43 NA NA NA -5.10 NA 
Hong 2012 -56.04 NA NA NA -9.91 NA 
Mean (SD) -51.24 (6.80) NA NA NA -7.51 (3.40) NA 
Median -51.24 NA NA NA -7.51 NA 
Non-randomized controlled trials 
Han 2016 -46.08 NA NA -15.85 NA NA 
Lim 2014 -27.71 -16.76 NA 2.18 NA NA 
You 2014 -27.62 NA NA -0.58 NA NA 
Choi 2014 -9.61 NA NA 3.43 NA NA 
M.-H. Kim 2015 -13.03 NA NA 6.99 NA NA 
Y. G. Kim 2015 -9.79 NA NA 3.93 NA NA 
Mean (SD) -22.31 (14.33) -16.76 NA 0.02 (8.15) NA NA 
Median -20.33 -16.76 NA 2.81 NA NA 
Non-randomized controlled trial with children 
Bang 2018 -21.13 NA NA -8.73 NA NA 
 
  
Table 5. Aggregated sample size (N) and studies providing data for each comparison 
Comparison N Primary studies’ first author and year 
Forest therapy versus no 
intervention/usual care 
525 Kim 2009; Woo 2012; Shin 2012; You 
2014; Lim 2014; Choi 2014; M-H. Kim 
2015; Y-G. Kim 2015; Bang 2018 
Forest therapy versus similar 
activities in a hospital 
134 Kim 2009; Woo 2012; Lim 2014 
Forest therapy versus similar 
activities in an urban area 
59 Chun 2017 
Forest therapy versus diet plus 
forest-based exercise 
31 Hong 2013; Hong 2012 
Forest therapy versus walking in 
a forest 
43 Woo 2012 
Note: Some forest therapy groups were counted in more than one comparison. Randomized 
controlled trials are in bold and cross-over trials are underlined.  The other studies are non-































Fig. 1. Flow diagram illustrating the selection process of primary studies. 
Records identified through the four 
systematic reviews (N = 101) 
Records excluded because they 
are duplicates or did not 
measure depression (N =   82) 
Full-text articles assessed 
for eligibility  































Full-text articles excluded 
with reasons (N = 6) 
# Studies that involved just 
exercising in forest (N = 3); 
# Studies in settings other than 
forest (N = 2); 
# We could not have access to 
one study. 
 
Studies synthesized  
(N = 13) 
Records screened 





Fig. 2. Results of randomized controlled trials: (a) Comparison of the post-intervention mean score of forest therapy groups versus no intervention/usual care 
using the inverse variance fixed-effect meta-analysis. (b) Comparison of the risk of temporary recovery from depression (i.e. remission) between forest 
therapy groups and usual care for depression groups, using the Mantel-Haenszel fixed-effect meta-analysis. (c) Comparison of the risk of response to 
treatment (i.e. ≥ 50% reduction on depressive symptoms) between forest therapy groups and no intervention/usual care groups, using the Mantel-Haenszel 
fixed-effect meta-analysis. Events refer to cases of remission (b) or response (c). Green squares refer to standardized mean differences and blues squares to 
risk ratios. Bigger squares indicated more participants in a study or more events and a bigger diamond indicates greater uncertainty in the estimate. Cross-





Fig. 3. Results of randomized controlled trials: (a) Comparison of the post-intervention mean score of forest therapy groups versus similar activities in hospital 
groups using the inverse variance fixed-effect meta-analysis. (b) Comparison of the risk of temporary recovery from depression (i.e. remission) between forest 
therapy groups and similar activities in hospital groups, using the Mantel-Haenszel fixed-effect meta-analysis. (c) Comparison of the risk of response to 
treatment (i.e. ≥ 50% reduction on depressive symptoms) between forest therapy groups and similar activities in hospital groups, using the Mantel-Haenszel 
fixed-effect meta-analysis. Events refer to cases of remission (b) or response (c). Green squares refer to standardized mean differences and blues squares to 
risk ratios. Bigger squares indicated more participants in a study or more events and a bigger diamond indicates greater uncertainty in the estimate. Cross-over 
and non-randomized controlled trials were analyzed separately. 
 
